Quick Answer
Processa Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $5.54 million for the year ending 2025.
- Processa Pharmaceuticals, Inc. showed an increase of +364.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Processa Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $1.39 million | Q1 2013: $421.5 thousand | Q2 2013: $629.8 thousand | Q3 2013: $1.00 million | Q4 2013: $186.9 thousand | Q1 2014: $82.2 thousand | Q2 2014: $39.9 thousand | Q3 2014: $55.7 thousand | Q4 2014: $21.2 thousand | Q1 2015: $41.8 thousand | Q2 2015: $15.2 thousand | Q3 2015: $15.1 thousand | Q1 2016: $2.4 thousand | Q2 2016: $14.9 thousand | Q3 2016: $6.7 thousand | Q1 2017: $1.01 million | Q2 2017: $715.1 thousand | Q3 2017: $1.04 million | Q4 2017: $2.85 million | Q1 2018: $1.78 million | Q2 2018: $2.85 million | Q3 2018: $2.42 million | Q1 2019: $1.25 million | Q2 2019: $722.0 thousand | Q3 2019: $504.3 thousand | Q1 2020: $142.3 thousand | Q2 2020: $452.7 thousand | Q3 2020: $325.4 thousand | Q1 2021: $23.05 million | Q2 2021: $20.83 million | Q3 2021: $19.09 million | Q1 2022: $14.39 million | Q2 2022: $12.06 million | Q3 2022: $9.05 million | Q1 2023: $10.74 million | Q2 2023: $8.68 million | Q3 2023: $6.86 million | Q1 2024: $8.92 million | Q2 2024: $5.57 million | Q3 2024: $2.89 million | Q1 2025: $2.90 million | Q2 2025: $6.94 million | Q3 2025: $6.31 million.
- Over the full 15 years of available data (2011 to 2025), Processa Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 98.1%.
- Historical annual values: Fiscal year 2025: $5.54 million | Fiscal year 2024: $1.19 million | Fiscal year 2023: $4.71 million | Fiscal year 2022: $6.50 million | Fiscal year 2021: $16.50 million | Fiscal year 2020: $15.42 million | Fiscal year 2019: $691.5 thousand | Fiscal year 2018: $1.74 million | Fiscal year 2017: $2.85 million | Fiscal year 2016: $1.07 million | Fiscal year 2015: $2.1 thousand | Fiscal year 2014: $21.2 thousand | Fiscal year 2013: $186.9 thousand | Fiscal year 2012: $1.02 million | Fiscal year 2011: $2.79 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: